Stay updated on Immunotherapy Platform in Cutaneous Melanoma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy Platform in Cutaneous Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy Platform in Cutaneous Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.3.3 was added to the study record history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-23T17:06:58.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The page history shows a new revision 3.3.2 was added and revision 3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T18:53:56.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The government funding notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T18:03:55.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Version 2 (2022-11-16) updated the Recruitment Status for the study NCT05572463 on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2025-11-03T12:56:51.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    13%
    Check dated 2025-10-05T17:39:39.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive changes.
    Difference
    0.3%
    Check dated 2025-09-28T11:11:54.000Z thumbnail image

Stay in the know with updates to Immunotherapy Platform in Cutaneous Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Cutaneous Melanoma Clinical Trial page.